Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-13

Clinical Trial Update: Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of adding saxagliptin to insulin therapy with or without metformin in adults with type 2 diabetes. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • Saxagliptin (saxagliptin)
  • metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-12-13